Logo wahanariau.com
  2. Junshi biosciences

Junshi biosciences

Index
Globenewswire

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates

Sabtu, 30 Maret 2024 - 05:34:00 Wib
Globenewswire

Junshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences Authority

Jumat, 02 Februari 2024 - 12:11:08 Wib
Globenewswire

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

Kamis, 18 Januari 2024 - 12:25:15 Wib
Globenewswire

Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine

Rabu, 10 Januari 2024 - 12:30:00 Wib
Globenewswire

Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients

Selasa, 02 Januari 2024 - 20:30:00 Wib
Globenewswire

Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA

Sabtu, 02 Desember 2023 - 22:00:00 Wib
Globenewswire

Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19

Kamis, 23 November 2023 - 22:30:00 Wib
Globenewswire

Junshi Biosciences Presents 11 Clinical Trials of Toripalimab at the ESMO Congress 2023

Jumat, 27 Oktober 2023 - 22:13:00 Wib
Globenewswire

Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates

Kamis, 31 Agustus 2023 - 22:02:00 Wib
Globenewswire

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as the First-line Treatment of Extensive-stage Small Cell Lung Cancer

Kamis, 20 Juli 2023 - 20:00:00 Wib
Globenewswire

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab

Rabu, 12 Juli 2023 - 22:10:00 Wib
Globenewswire

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer

Kamis, 29 Juni 2023 - 22:00:00 Wib